Tdspharm Co., Ltd. (KOSDAQ:464280)
8,280.00
+280.00 (3.50%)
Apr 8, 2026, 3:30 PM KST
Tdspharm Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,213 | 4,704 | 1,636 | 2,937 | 1,622 |
Short-Term Investments | 19,000 | 26,000 | 13,500 | 7,000 | 6,500 |
Cash & Short-Term Investments | 20,213 | 30,704 | 15,136 | 9,937 | 8,122 |
Cash Growth | -34.17% | 102.86% | 52.32% | 22.34% | 10.66% |
Accounts Receivable | 6,444 | 5,182 | 6,575 | 5,596 | 3,013 |
Other Receivables | 289.86 | 480.95 | 230.7 | 102.73 | 1.39 |
Receivables | 6,879 | 5,743 | 6,806 | 5,699 | 3,014 |
Inventory | 2,597 | 3,151 | 2,493 | 2,163 | 1,939 |
Prepaid Expenses | 23.3 | 16.67 | 8.53 | 8.75 | 10.66 |
Other Current Assets | 103.6 | 24.61 | 36.15 | 142.14 | 47.95 |
Total Current Assets | 29,816 | 39,640 | 24,480 | 17,950 | 13,134 |
Property, Plant & Equipment | 20,729 | 8,881 | 8,917 | 9,705 | 10,207 |
Long-Term Investments | 54.47 | - | - | 1,969 | 3,384 |
Other Intangible Assets | 130.2 | 173 | 51.54 | -0 | -0 |
Long-Term Deferred Tax Assets | 154.32 | 162.43 | 207.95 | 493.84 | - |
Long-Term Deferred Charges | 83.82 | 115.26 | 146.69 | 157.17 | 151.67 |
Other Long-Term Assets | 3,184 | 188.95 | 167.01 | 193.54 | 90.16 |
Total Assets | 54,152 | 49,161 | 33,970 | 30,469 | 26,967 |
Accounts Payable | 2,265 | 1,543 | 2,266 | 2,220 | 1,249 |
Accrued Expenses | 109.58 | 68.3 | 73.61 | 75.04 | 45.56 |
Short-Term Debt | 7,594 | 6,000 | 6,000 | 6,000 | 7,000 |
Current Portion of Long-Term Debt | - | 775 | 200 | - | - |
Current Portion of Leases | 55.02 | 79.16 | 75.74 | 102.2 | 49.82 |
Current Income Taxes Payable | 343.31 | 1,078 | 273.57 | 411.92 | 408.58 |
Other Current Liabilities | 839.6 | 974.03 | 1,176 | 1,021 | 832.78 |
Total Current Liabilities | 11,206 | 10,517 | 10,065 | 9,830 | 9,585 |
Long-Term Debt | - | - | 775 | 675 | - |
Long-Term Leases | 62.49 | 72.04 | 94.7 | 173.89 | 90.34 |
Pension & Post-Retirement Benefits | - | - | 35.37 | 1,421 | 1,094 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 23.19 |
Other Long-Term Liabilities | 97.98 | 67.03 | 55.05 | 59.91 | 31.22 |
Total Liabilities | 11,367 | 10,656 | 11,025 | 12,160 | 10,824 |
Common Stock | 553 | 553 | 500 | 500 | 500 |
Additional Paid-In Capital | 9,970 | 9,970 | - | - | - |
Retained Earnings | 33,568 | 29,294 | 25,736 | 21,260 | 17,804 |
Treasury Stock | -881.35 | -881.35 | -2,706 | -2,706 | -2,706 |
Comprehensive Income & Other | -425.07 | -431.07 | -584.88 | -745.34 | 544.66 |
Shareholders' Equity | 42,785 | 38,504 | 22,945 | 18,308 | 16,143 |
Total Liabilities & Equity | 54,152 | 49,161 | 33,970 | 30,469 | 26,967 |
Total Debt | 7,712 | 6,926 | 7,145 | 6,951 | 7,140 |
Net Cash (Debt) | 12,501 | 23,778 | 7,991 | 2,986 | 982.27 |
Net Cash Growth | -47.43% | 197.58% | 167.60% | 203.99% | 249.25% |
Net Cash Per Share | 2363.06 | 5135.78 | 1876.65 | 700.79 | 10630.51 |
Filing Date Shares Outstanding | 5.3 | 5.29 | 4.26 | 4.26 | 0.09 |
Total Common Shares Outstanding | 5.3 | 5.29 | 4.26 | 4.26 | 0.09 |
Working Capital | 18,609 | 29,123 | 14,414 | 8,120 | 3,549 |
Book Value Per Share | 8079.38 | 7280.75 | 5388.68 | 4296.83 | 174704.28 |
Tangible Book Value | 42,655 | 38,331 | 22,893 | 18,308 | 16,143 |
Tangible Book Value Per Share | 8054.79 | 7248.04 | 5376.58 | 4296.83 | 174704.29 |
Land | 10,497 | 2,020 | 2,020 | 2,020 | 2,020 |
Buildings | 8,589 | 7,420 | 7,531 | 7,531 | 7,531 |
Machinery | 8,028 | 9,114 | 8,599 | 8,457 | 8,088 |
Construction In Progress | 2,040 | 231.19 | 190.08 | 127.21 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.